Beranda › Kanker Mulut › Illinois › Evanston
Uji klinis Kanker Mulut di Evanston, IL
4 studi untuk Kanker Mulut mencari peserta di lokasi sekitar Evanston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Menerima pesertaFase 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauhnya
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Menerima pesertaFase 2
- Advocate Lutheran General Hospital, Park Ridge · 8 mi jauhnya
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Menerima pesertaFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi jauhnya
Uji klinis Kanker Mulut di kota lain
- Atlanta, GA9 studi
- St. Louis, MO8 studi
- New York City, NY8 studi
- Chicago, IL8 studi
- Durham, NC7 studi
- Houston, TX7 studi
- Ann Arbor, MI7 studi
- Portland, OR7 studi
- Pittsburgh, PA7 studi
- Milwaukee, WI7 studi
- Kansas City, MO7 studi
- Richmond, VA7 studi
Studi lain di Evanston
- Kanker Paru Non-Sel Kecil22 studi
- Kanker Paru19 studi
- Kanker Payudara13 studi
- Obesitas12 studi
- Leukemia Mieloid Akut11 studi
- Kelebihan Berat Badan10 studi
- Kanker Kolorektal10 studi
- Kanker (semua jenis)9 studi
- Penyakit Crohn9 studi
- Kolitis Ulseratif9 studi
- Kanker Prostat9 studi
- Melanoma8 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.